DEFINITIVE PROXY STATEMENT

Company

Actinium Pharmaceuticals, Inc.

Filed

November 14, 2014

Period of Report

December 22, 2014

Accession Number

0001213900-14-008245

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →